Adaptimmune

This early-stage study tested whether a patient's own immune cells could be genetically modified in a lab to recognize and attack cancer cells, then safely given back to the patient. It involved 10 adults with specific types of bladder, skin (melanoma), or head and neck cancers w…

This early-stage trial tested a new treatment for advanced lung cancer that has stopped responding to standard therapies. Doctors collected immune cells from 28 patients, genetically modified them in a lab to target cancer, and then infused them back into the patients. The main g…